Boai NKY Pharmaceuticals Ltd (300109) — Capital Reinvestment Ratio
Boai NKY Pharmaceuticals Ltd (300109) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥139.46 Million) in capital expenditures (CN¥41.41 Million). See net asset quality index of Boai NKY Pharmaceuticals Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Boai NKY Pharmaceuticals Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks Boai NKY Pharmaceuticals Ltd's Capital Reinvestment Ratio across 18 annual periods. Check Boai NKY Pharmaceuticals Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Boai NKY Pharmaceuticals Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for Boai NKY Pharmaceuticals Ltd from 2007 to 2025. For live market cap and broader valuation context, see Boai NKY Pharmaceuticals Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | CN¥338.11 Million | CN¥220.42 Million | ▼ -39.2% |
| 2024 | 1.07x | CN¥256.03 Million | CN¥274.68 Million | ▲ +38.6% |
| 2023 | 0.77x | CN¥488.25 Million | CN¥377.88 Million | ▼ -26.7% |
| 2022 | 1.06x | CN¥251.77 Million | CN¥266.00 Million | ▼ -79.9% |
| 2021 | 5.26x | CN¥43.44 Million | CN¥228.32 Million | ▲ +1313.4% |
| 2020 | 0.37x | CN¥266.87 Million | CN¥99.24 Million | ▼ -79.2% |
| 2019 | 1.79x | CN¥79.64 Million | CN¥142.35 Million | ▼ -29.9% |
| 2018 | 2.55x | CN¥48.81 Million | CN¥124.37 Million | ▼ -6.8% |
| 2017 | 2.73x | CN¥47.28 Million | CN¥129.23 Million | ▲ +543.7% |
| 2016 | 0.42x | CN¥114.14 Million | CN¥48.47 Million | ▼ -32.7% |
| 2015 | 0.63x | CN¥64.12 Million | CN¥40.48 Million | ▼ -37.6% |
| 2014 | 1.01x | CN¥46.60 Million | CN¥47.11 Million | ▼ -34.0% |
| 2013 | 1.53x | CN¥23.17 Million | CN¥35.47 Million | ▼ -65.3% |
| 2012 | 4.41x | CN¥20.65 Million | CN¥90.96 Million | ▼ -83.4% |
| 2011 | 26.46x | CN¥3.94 Million | CN¥104.29 Million | ▲ +1144.2% |
| 2010 | 2.13x | CN¥10.05 Million | CN¥21.38 Million | ▲ +140.5% |
| 2009 | 0.88x | CN¥28.57 Million | CN¥25.27 Million | ▲ +77.3% |
| 2007 | 0.50x | CN¥9.56 Million | CN¥4.77 Million | — |